Off-Label Prescriptions in Dermatology: Challenges of New Routes of Administration for Certain Old Drugs

被引:1
|
作者
Tasic-Kostov, Marija [1 ]
Ilic, Dusan [1 ]
机构
[1] Univ Nis, Fac Med, Dept Pharm, Nish, Serbia
关键词
off-label drug; dermatology; compounded drugs; drug vehicle; INFANTILE HEMANGIOMAS; TOPICAL PROPRANOLOL; SPIRONOLACTONE; THERAPY; SAFETY; ACNE; GEL;
D O I
10.5937/afmnai37-25282
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
"Off-label drug use" refers to the prescription of medications, with reference to indications, dosage, dosage form, patient group or route of administration, which are officially unapproved. Recently, new indications for some drugs have emerged and few of them are being used off-label to treat topically a variety of dermatological conditions. Off-label use is more common in dermatology than in other medical specialties, and those drugs are basically available as compounded formulations, but the choice of a proper vehicle and safety of extemporaneous drug preparation intended for topical use are usually neglected in case of systemic drugs. Moreover, the bases commonly used as vehicles for extemporaneous dermatological preparations are stabilized with traditional surfactants known for their potential to irritate skin, while inflammatory dermatoses can worsen when exposed to irritants In this paper, we have listed several systemic drugs which are being used in topical treatment of some frequent dermatological conditions, but not according to their officially approved indications. The choice of drugs was made according to the topical off-label dermatological prescriptions obtained from public pharmacies. The aim was also to review data related to, in our opinion, two major drawbacks of using off-label topical drugs: safety data on the use of the final dermal preparation and scientific information relevant for the choice of a proper topical vehicle for specific drug and proper stability evaluation.
引用
收藏
页码:131 / 138
页数:8
相关论文
共 50 条
  • [41] Off-label drug prescriptions on the rise among physicians
    不详
    COMPENDIUM ON CONTINUING EDUCATION FOR THE PRACTICING VETERINARIAN, 2006, 28 (07): : 491 - 491
  • [42] The off-label prescriptions Authorisation on the Market in children and adolescents
    Venel, V.
    Petron-Bardou, C.
    EUROPEAN PSYCHIATRY, 2013, 28 (08) : 92 - 92
  • [43] Off-Label Prescriptions in Italian Hospices: A National Survey
    Toscani, Franco
    Di Giulio, Paola
    Campi, Rita
    Pellerin, Ivanoe
    De Luca, Anna
    Casale, Giuseppe
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2009, 38 (03) : 365 - 371
  • [44] Off-label drugs for obesity Comment
    Proietto, Joseph
    AUSTRALIAN PRESCRIBER, 2022, 45 (04) : 114 - 114
  • [45] Off-label use of approved drugs
    Landow, L
    CHEST, 1999, 116 (03) : 589 - 591
  • [46] Off-Label Use of Drugs and Devices
    Rosenfeld, Philip J.
    Goodman, Kenneth W.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2010, 149 (01) : 170 - 171
  • [47] Off-Label Prescribing of Drugs for Children
    Wertheimer, Albert
    CURRENT DRUG SAFETY, 2011, 6 (01) : 46 - 48
  • [48] Off-label uses of drugs for depression
    Skanland, Sigrid S.
    Cieslar-Pobuda, Artur
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2019, 865
  • [49] Off-label and unlicensed drugs in neonatology
    Rite-Gracia, Segundo
    Avila-Alvarez, Alejandro
    ANALES DE PEDIATRIA, 2021, 94 (03): : 127 - 128
  • [50] Controlled use of off-label drugs
    Seeber, S
    EUROPEAN JOURNAL OF CANCER, 2003, 39 (09) : 1189 - 1189